Titled, “Breakthrough Technologies Transform the Discovery and Development of Peptide Drugs.”
The article looks at how Pepticom designs ab initio novel peptide drug candidates using proprietary AI-driven biocomputational software.
You can read the whole article here:
https://lnkd.in/gc3G-Shh
